Taiko Pharmaceutical Co.,Ltd. (TYO:4574)
Japan · Delayed Price · Currency is JPY 277.00
-3.00 (-1.07%)
Jul 16, 2025, 3:30 PM JST
Taiko Pharmaceutical Revenue
Taiko Pharmaceutical had revenue of 1.15B JPY in the quarter ending March 31, 2025, a decrease of -16.49%. This brings the company's revenue in the last twelve months to 6.07B, down -4.19% year-over-year. In the year 2024, Taiko Pharmaceutical had annual revenue of 6.29B with 2.81% growth.
Revenue (ttm)
6.07B
Revenue Growth
-4.19%
P/S Ratio
2.29
Revenue / Employee
28.34M
Employees
214
Market Cap
13.90B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.29B | 172.00M | 2.81% |
| Dec 31, 2023 | 6.12B | 1.08B | 21.43% |
| Dec 31, 2022 | 5.04B | -6.26B | -55.39% |
| Dec 31, 2021 | 11.30B | -11.16B | -49.68% |
| Dec 31, 2020 | 22.46B | 7.49B | 50.05% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 866.03B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Shionogi & | 438.27B |